Ratings by Deutsche Bank (James Shin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Ascentage Pharma Group | AAPG | New Coverage | Buy (N/A) |
25.13 (18.20) |
-27.58% | Details | |
| 3/27/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Merck | MRK | Upgrade | Buy (Hold) |
119.24 (135.17) |
13.36% | Details | |
| 2/11/2026 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2026 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2025 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 9/15/2025 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Immatics | IMTX | New Coverage | Buy (N/A) |
5.11 (9.09) |
77.89% | Details | |
| 5/27/2025 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
31.21 (36.02) |
15.41% | Details | |
| 2/26/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
104.08 (143.44) |
37.82% | Details | |
| 2/18/2025 | Merck | MRK | Downgrade | Hold (Buy) |
83.01 (135.17) |
62.84% | Details | |
| 2/10/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 12/11/2024 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 10/3/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 9/6/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 9/3/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 8/27/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Eli Lilly | LLY | Upgrade | Buy (Hold) |
891.68 (1225.73) |
37.46% | Details | |
| 7/23/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 7/17/2024 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 5/24/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 5/23/2024 | Legend Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
42.60 (21.92) |
-48.54% | Details | |
| 5/23/2024 | Incyte | INCY | New Coverage | Hold (N/A) |
58.20 (123.47) |
112.15% | Details | |
| 5/14/2024 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 4/5/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2024 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2024 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/2/2024 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2024 | Abbvie | ABBV | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2024 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/20/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2023 | Immunogen Inc. | IMGN | New Coverage | Buy (N/A) |
15.98 (31.25) |
95.56% | Details | |
| 11/9/2023 | Merck | MRK | New Coverage | Buy (N/A) |
104.00 (135.17) |
29.97% | Details | |
| 11/9/2023 | Gilead Sciences | GILD | New Coverage | Hold (N/A) |
80.61 (143.44) |
77.94% | Details | |
| 11/9/2023 | Bristol-Myers Squibb Co. | BMY | New Coverage | Hold (N/A) |
52.29 (66.05) |
26.31% | Details | |
| 11/9/2023 | Autolus Therapeutics plc | AUTL | New Coverage | Buy (N/A) |
3.68 (2.29) |
-37.77% | Details | |
| 11/9/2023 | Eli Lilly | LLY | New Coverage | Hold (N/A) |
599.93 (1225.73) |
104.31% | Details | |
| 11/9/2023 | Abbvie | ABBV | New Coverage | Hold (N/A) |
142.16 (258.92) |
82.13% | Details | |
| 11/9/2023 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
2.62 (22.04) |
741.22% | Details | |
| 11/9/2023 | Regeneron Pharma | REGN | New Coverage | Hold (N/A) |
830.79 (810.24) |
-2.47% | Details | |
| 11/9/2023 | Amgen | AMGN | New Coverage | Hold (N/A) |
271.11 (425.28) |
56.87% | Details |
